381 related articles for article (PubMed ID: 16931942)
21. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
[TBL] [Abstract][Full Text] [Related]
22. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.
Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA
Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980
[TBL] [Abstract][Full Text] [Related]
23. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
[TBL] [Abstract][Full Text] [Related]
24. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse.
Kumar MS; Virk HK; Chaudhuri A; Mittal A; Lewis G
Int J Drug Policy; 2008 Apr; 19(2):148-58. PubMed ID: 18221862
[TBL] [Abstract][Full Text] [Related]
25. The onset of drug injection among sex partners of injection drug users.
Ouellet LJ; Rahimian A; Wiebel WW
AIDS Educ Prev; 1998 Aug; 10(4):341-50. PubMed ID: 9721386
[TBL] [Abstract][Full Text] [Related]
26. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
[TBL] [Abstract][Full Text] [Related]
27. Trends in sexual behaviour and the incidence of sexually transmitted diseases and HIV among drug-using prostitutes, Amsterdam 1986-1992.
van Ameijden EJ; van den Hoek AJ; van Haastrecht HJ; Coutinho RA
AIDS; 1994 Feb; 8(2):213-21. PubMed ID: 8043226
[TBL] [Abstract][Full Text] [Related]
28. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
[TBL] [Abstract][Full Text] [Related]
29. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
[TBL] [Abstract][Full Text] [Related]
30. [Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, I994-2002].
de Boer IM; Op de Coul EL; Beuker RJ; de Zwart O; Al Taqatqa W; van de Laar MJ
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2325-30. PubMed ID: 15587051
[TBL] [Abstract][Full Text] [Related]
31. [HIV prevalence among Surinam and Antillean drug users in Amsterdam].
Fennema JS; van den Hoek JA; Huisman JG; Coutinho RA
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2209-13. PubMed ID: 8247167
[TBL] [Abstract][Full Text] [Related]
32. [Little HIV risk behavior in drug users during detention in Dutch penitentiaries].
van Haastrecht HJ; Bax JS; van den Hoek JA
Ned Tijdschr Geneeskd; 1997 Mar; 141(9):429-33. PubMed ID: 9173303
[TBL] [Abstract][Full Text] [Related]
33. Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?
van Houdt R; van den Berg CH; Stolte IG; Bruisten SM; Dukers NH; Bakker M; Wolthers KC; Prins M; Coutinho RA
J Med Virol; 2009 Jul; 81(7):1163-9. PubMed ID: 19475623
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year.
Hart GJ; Carvell AL; Woodward N; Johnson AM; Williams P; Parry JV
AIDS; 1989 May; 3(5):261-5. PubMed ID: 2504229
[TBL] [Abstract][Full Text] [Related]
35. Drug use and HIV risk practices of secondary and primary needle exchange users.
Huo D; Bailey SL; Hershow RC; Ouellet L
AIDS Educ Prev; 2005 Apr; 17(2):170-84. PubMed ID: 15899754
[TBL] [Abstract][Full Text] [Related]
36. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
37. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users.
Van Ameijden EJ; Langendam MW; Notenboom J; Coutinho RA
Addiction; 1999 Jul; 94(7):1051-61. PubMed ID: 10707443
[TBL] [Abstract][Full Text] [Related]
38. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
[TBL] [Abstract][Full Text] [Related]
39. [Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].
Keizer ST; Langendam MW; van Deutekom H; Coutinho RA; van Ameijden FJ
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):184-9. PubMed ID: 9557024
[TBL] [Abstract][Full Text] [Related]
40. Clustered drug and sexual HIV risk among a sample of middle-aged injection drug users, Houston, Texas.
Noor SW; Ross MW; Lai D; Risser JM
AIDS Care; 2013; 25(7):895-903. PubMed ID: 23092216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
